Effective, Noninvasive, Nonpharmacological Obesity Treatment for Patients with Cardiovascular Risks
By Andrea M. Pampaloni, Ph.D.
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, and in the United States someone dies every 36 seconds from the disease. Despite advanced knowledge and its risk factors — and having the medical and technological treatments to help prevent it — incidents of heart failure have been on the rise since 2012 after a 30 year decline. The key factors contributing to this reversal? Obesity and diabetes.
Both epidemics themselves, obesity and diabetes, are closely linked and collectively responsible for about a million deaths each year. Because both are significant cardiometabolic risk factors, an obesity diagnosis and a candid discussion of weight loss and maintenance strategies are critical.